The activation of PPARα likely contributed to the reduction in hepatic triglycerides and total cholesterol levels in the LC-CHF group, as enhanced β-oxidation reduces lipid storage in the liver and adipose tissues. The gene discussed is PPARA; the disease is congestive heart failure.